Table 2.
Cancer characteristics according to fractionation regimen
| Fractionation regimen (No. of patients) |
|||
|---|---|---|---|
| Characteristics | conventional (n = 51) | hyper-fractionation (n = 50) | accelerated (n = 51) |
| Primary site: | |||
| larynx | 28 | 27 | 29 |
| oropharynx | 16 | 17 | 16 |
| hypopharynx | 7 | 6 | 6 |
| T stage: | |||
| T1 | 2 | 2 | 1 |
| T2 | 9 | 11 | 10 |
| T3 | 26 | 24 | 28 |
| T4 | 14 | 13 | 12 |
| N stage: | |||
| N0 | 24 | 21 | 26 |
| N1 | 7 | 8 | 6 |
| N2 | 15 | 13 | 12 |
| N3 | 5 | 8 | 7 |
| UICC/AJCC* stage: | |||
| I | 2 | 2 | 1 |
| II | 8 | 10 | 7 |
| III | 18 | 15 | 21 |
| IV | 23 | 23 | 22 |
*International Union Against Cancer (UICC) and American Joint Committee of Cancer (AJCC) classification of TNM stages.